[{"NetIncomeLossConverted_1_FY_USD":-3635000.0,"NetIncomeLossConverted_4_FY_USD":-22548000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":11964000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":15267000.0,"EarningsPerShareDiluted_4_FY_USD":-1.88,"EarningsPerShareDiluted_1_FY_USD":-0.3,"StockholdersEquity_0_FY_USD":195700000.0,"RevenuesConverted_4_FY_USD":208475000.0,"RevenuesConverted_1_FY_USD":57252000.0,"Assets_0_FY_USD":461190000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":11964000.0,"EarningsPerShareBasic_4_FY_USD":-1.88,"EarningsPerShareBasic_1_FY_USD":-0.3,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210311"}]